Special Issue "Recent Advances in Computational Drug Discovery: From In Silico Screening to Multiscale De Novo Drug Design"
Deadline for manuscript submissions: closed (31 January 2020).
Interests: Multi-Scale De Novo Drug Design, Multi-Scale Models, QSAR-Based Approaches, Chemoinformatics, Bioinformatics, Big Data and Data Mining, Computer-Aided Drug Discovery, and Virtual Screening
Diseases continue to plague modern societies, and over time, through the process known as drug discovery, a plethora of therapeutic options has been introduced to cure illnesses. Unfortunately, most of them remain as unresolved health issues. The experience accumulated demonstrates that the scientific community still faces several challenges in drug development. On one hand, it is well-established that the chemical space to be covered in the search for new drugs is vast, being formed by approximately 1060 small molecules. On the other hand, diseases are difficult to treat because of their multifactorial nature, which in many cases is related to phenomena such as drug resistance. Further, most of the current drugs are associated with a broad spectrum of side effects. Consequently, designing a new drug is increasingly expensive, complex, and time-consuming, taking 12–17 years with a cost of around US$3 billion.
Today, to accelerate and improve drug discovery, there is a pressing need to exploit and integrate the huge amounts of data coming from the domains of the chemical, biological, and biomedical sciences. In this context, in silico approaches have become an integral part of all the drug discovery projects, helping to rationalize the design of potent and versatile therapeutic agents.
In this Special Issue of Molecules, we are inviting the scientific community to submit original research contributions, short communications, or review articles that highlight the most recent advances in the applications of in silico approaches to all the areas involved in drug discovery.
Prof. Alejandro Speck-Planche
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2000 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- Virtual screening
- De novo design
- Big data and data mining
- Machine learning
- Network modeling
- Multiscale models